CP1 cannpal animal therapeutics limited
Add to My Watchlist 0.00% ! 17.0¢

News: CP1 Auscann Group Holdings Says Nick Woolf Has Decided To Resign As CEO

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    08/01/21
    12:20
    Post #: 50032693

    Jan 8 (Reuters) - Auscann Group Holdings Ltd (AC8) :

    • AUSCANN LEADERSHIP POST CANNPAL ACQUISITION,CP1-AC8.AX
    • NICK WOOLF HAS DECIDED TO TENDER HIS RESIGNATION AS CEO
    • NICK WOOLF HAS AGREED TO STAY WITH AUSCANN AS INTERIM CEO
    • FOUNDER AND MANAGING DIRECTOR OF CANNPAL LAYTON MILLS WILL LEAD COMBINED CO WITH CANNPAL ANIMAL THERAPEUTICS
    • NICK WOOLF TO STAY WITH AUSCANN AS INTERIM CEO UNTIL COMPLETION OF TRANSACTION
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.